Bunge Global S.A. (BG)

FairStock Score: 39/100 — MIXED

Key Financials

Strengths

• Global scale and integrated operations across four major processing segments
• Low beta of 0.74 provides defensive characteristics in volatile markets
• Positive FCF yield of 3.6% suggests some cash generation capability
• Essential role in agricultural supply chain with stable long-term demand

Concerns

• Abysmal profitability: 0.40% net margin with negative $7.1B free cash flow signals structural problems
• Returns on capital are unacceptable: ROCE 2.51%, ROE 5.96%—destroying shareholder value
• Valuation is unjustifiable: Trading at 3.9x Graham Number with 70.64x EV/EBITDA for a commodity business
• Deteriorating financial health: Altman Z-Score 1.72, negative FCF, and leverage of 0.91 D/E ratio

AI Analysis

I've examined Bunge Global carefully, and I must be candid: this is not a compelling opportunity at current valuation. Let me explain my reasoning. Bunge operates in commodity-driven agribusiness—inherently cyclical, with thin margins. Their latest quarter illustrates this brutal reality: $23.8 billion in revenue produced a mere $95 million in net income, a 0.40% margin. This is not a business that compounds wealth. The financial metrics trouble me significantly. Their ROCE of 2.51% is atrocious—far below our cost of capital. A company generating only $0.03 of economic value per dollar of capital employed destroys shareholder value. Their ROE of 5.96% is equally disappointing. Free cash flow turned deeply negative at -$7.1 billion, suggesting capital intensity without proportional returns. Valuation compounds the problem. At $116.67, Bunge trades at a P/B of 1.44 with a Graham Number of just $30.11—meaning our margin of safety is catastrophically negative at -287%. The EV/EBITDA ratio of 70.64 is astronomical for a commodity business. This represents gross overpayment. The balance sheet shows leverage (D/E: 0.91) alongside deteriorating returns. The Altman Z-Score of 1.72 suggests financial stress. A Piotroski F-Score of 6/9 indicates operational weakness. Even their low beta of 0.74 cannot justify the risk-return profile. Bunge lacks the durable competitive advantages Graham and I demand. Commodity merchants face perpetual price competition with limited pricing power. I see a capital-intensive, cyclical business trading at peak valuations with mediocre returns. This is precisely the type of investment I avoid.

Bull Case

Agricultural commodities may see structural supply constraints and higher prices in coming years, benefiting Bunge's processing volumes. The company's global scale and integrated operations position it to capture margins if commodity spreads widen meaningfully.

Bear Case

Commodity price weakness, global oversupply, or economic recession would compress already-thin margins further. The company's heavy capital requirements and negative free cash flow could force deleveraging or dividend cuts, destroying shareholder returns.

Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer